ArticleBMJ open2022

Phase III, international, multicentre, double-blind, dose increment, parallel-arm, randomised controlled trial of duloxetine versus pregabalin for opioid-unresponsive neuropathic cancer pain: a JORTC-PAL16 trial protocol.

Hiromichi Matsuoka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.